title: Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.
abstract: BACKGROUND
  Insulin-like growth factor-1 (IGF-1) has specific effects on axonal growth and myelination, low CSF IGF-1 levels being found in some severe neurologic diseases. We studied the levels of CSF IGF-1 and IGF binding protein-2 (IGFBP-2) in children with ALL to find out whether these levels correlated with any of the neurological deficits observed.
  
  
  METHODS
  IGF-1 and IGFBP-2 levels were prospectively measured by radioimmunoassay in the CSF of 14 children with ALL throughout the ALL chemotherapy. These were compared with the levels of 16 control subjects and of patient groups with severe neurological diseases.
  
  
  RESULTS
  During induction, the children with ALL had subnormal CSF IGF-1 levels which improved after 2 months. In seven individuals, two with severe vincristine polyneuropathy, the subnormal levels persisted throughout the chemotherapy.
  
  
  CONCLUSIONS
  Our findings suggest impairment of the IGF-1 trophic system during induction by a mechanism so far unknown. Correlation with disturbed neuronal function could not be statistically proven.
authors.affiliation: Children's Hospital, University of Kuopio, Finland. Raili.Riikonen@kuh.fi
authors.forename: Raili
authors.initials: R
authors.lastname: Riikonen
authors.forename: Kim
authors.initials: K
authors.lastname: Vettenranta
authors.forename: Pekka
authors.initials: P
authors.lastname: Riikonen
authors.forename: U
authors.initials: U
authors.lastname: Turpeinen
authors.forename: Ulla M
authors.initials: UM
authors.lastname: Saarinen-Pihkala
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016022:Case-Control Studies; D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000134:cerebrospinal fluid / Q000187:drug effects*; D007334:Insulin-Like Growth Factor I / Q000134:cerebrospinal fluid / Q000187:drug effects*; D010865:Pilot Projects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D018709:Statistics, Nonparametric
chemical_list: D018971:Insulin-Like Growth Factor Binding Protein 2; D007334:Insulin-Like Growth Factor I